SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-220200
Filing Date
2012-05-09
Accepted
2012-05-09 07:06:20
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d330193d10q.htm 10-Q 560783
2 EXHIBIT 31.1 d330193dex311.htm EX-31.1 9831
3 EXHIBIT 31.2 d330193dex312.htm EX-31.2 9847
4 EXHIBIT 32.1 d330193dex321.htm EX-32.1 5495
  Complete submission text file 0001193125-12-220200.txt   2508488

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vnda-20120331.xml EX-101.INS 364690
6 XBRL TAXONOMY EXTENSION SCHEMA vnda-20120331.xsd EX-101.SCH 12983
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20120331_cal.xml EX-101.CAL 33751
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20120331_def.xml EX-101.DEF 9682
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20120331_lab.xml EX-101.LAB 122484
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20120331_pre.xml EX-101.PRE 77413
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34186 | Film No.: 12823751
SIC: 2834 Pharmaceutical Preparations